Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
TERMINATED
NCT04420624
PHASE2/PHASE3

COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction

Sponsor: University Hospital, Montpellier

View on ClinicalTrials.gov

Summary

This study evaluates the benefit of colchicine on induced denervation after myocardial infarction. Patients who have suffered a documented De Novo myocardial infarction and completed a revascularization procedure will receive either colchicine on top of standard therapy, compared to standard therapy alone (1:1 allocation ratio). Colchicine 1mg (or 0.5mg) will be initiated within 48h after percutaneous revascularization and prescribed for one month.

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

54

Start Date

2020-12-04

Completion Date

2022-05-24

Last Updated

2026-06-12

Healthy Volunteers

No

Interventions

DRUG

Colchicine

1 mg (or 0.5mg) tablet of colchicine taken once a day for 1 month

Locations (1)

UH Montpellier

Montpellier, France